PMI Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Picard Medical, Inc. Class Action

Core Viewpoint - A class action lawsuit has been filed against Picard Medical, Inc. for allegedly being involved in a fraudulent stock promotion scheme that misled investors [2][4]. Group 1: Allegations - The lawsuit claims that Picard Medical failed to disclose that it was the subject of a fraudulent stock promotion scheme involving misinformation on social media and impersonated financial professionals [2]. - It is alleged that insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign [2]. - The company's public statements and risk disclosures reportedly omitted any mention of false rumors and artificial trading activity that influenced the stock price [2]. Group 2: Stock Price Impact - On October 24, 2025, Picard's stock price experienced a significant crash of 70%, dropping to $3.99 per share [3]. - Following the crash, the company's share price has continued to decline, reaching approximately $2.00 per share [3]. Group 3: Class Action Participation - Shareholders interested in participating as lead plaintiffs in the class action must file their papers with the court by April 3, 2026 [4]. - Shareholders do not need to participate in the case to be eligible for recovery and can remain absent class members if they choose [4].